GlaxoSmithKline R&D reorganization triggers layoffs at Stevenage -- and Upper Providence
GSK’s new R&D chief Hal Barron has made no secret of the fact that he has a keen interest in refocusing the R&D group at the pharma giant. And that’s starting to play out with some layoffs in its big R&D center at GSK’s Stevenage campus as well as its second big hub near Philadelphia.
The pharma giant put out a statement earlier today noting that a “small number” of roles would be affected by the layoffs in Stevenage. Their statement:
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.